Uterine leiomyosarcoma (ULMS) is the most lethal gynecologic malignancy with few therapeutic options. Chemoresistance prevails as a major hurdle in treating this malignancy, yet the mechanism of chemoresistance remains largely unclear. In this study, we certified MELK as a poor prognostic marker through bioinformatic analysis of the GEO database. Cellular experiments revealed that MELK played an essential role in ULMS cells' chemoresistance and that a high expression of MELK could lead to doxorubicin resistance. mRNA profiling uncovered the pathways that MELK was involved in which led to doxorubicin resistance. MELK was found to affect ULMS cells' chemoresistance through an anti-apoptotic mechanism via the JAK2/STAT3 pathway. miRNA profiling also revealed that upregulated MELK could induce the decrease of miRNA-34a (regulated by JAK2/STAT3 pathway). We detected that MELK overexpression could induce M2 macrophage polarization via the miR-34a/JAK2/STAT3 pathway, contributing to doxorubicin chemoresistance in the tumor microenvironment. OTSSP167, a MELK inhibitor, may increase ULMS sensitivity to doxorubicin. Our investigation could propose novel targets for early diagnosis and precision therapy in ULMS patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188922PMC
http://dx.doi.org/10.3389/fonc.2020.00453DOI Listing

Publication Analysis

Top Keywords

upregulated melk
8
doxorubicin chemoresistance
8
macrophage polarization
8
polarization mir-34a/jak2/stat3
8
mir-34a/jak2/stat3 pathway
8
uterine leiomyosarcoma
8
melk
8
ulms cells'
8
cells' chemoresistance
8
doxorubicin resistance
8

Similar Publications

Esophageal squamous cell carcinoma (ESCC) remains a global health challenge. Circadian clock and Maternal embryonic leucine zipper kinase (MELK) play a key role in tumorigenesis. However, a link between circadian clock dysregulation and MELK function in the occurrence and development of ESCC remains elusive.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatocellular carcinoma (HCC) is a major cancer threat worldwide with few treatment options, prompting research into prognosis and therapy for patients with hepatitis B (HBV)-related HCC.
  • The study analyzed data from three microarray datasets, uncovering 374 differentially expressed genes, including significant hub genes linked to poor patient prognosis.
  • Key genes like ZWINT and CDK1 were identified as potential biomarkers, suggesting they could help predict disease progression and guide new treatment approaches, while further research is needed on other hub genes.
View Article and Find Full Text PDF

Background: Psoriasis and vitiligo are two common autoimmune skin diseases with increased risk of comorbidities, but the common molecular mechanism about the occurrence of these two diseases is still unknown.

Objective: This study aimed to identify the combined genetic profiles and evaluate the potential mechanism underlying the occurrence of this complication.

Methods: The Gene Expression Omnibus (GEO) database was used to obtain the gene expression profiles of psoriasis (GSE30999) and vitiligo (GSE75819), and common differentially expressed genes (DEGs) were identified using GEO2R.

View Article and Find Full Text PDF
Article Synopsis
  • Esophageal chemical burns, resulting from accidental or intentional ingestion of harmful chemicals, can lead to severe complications, including esophageal cancer, which includes squamous cell carcinoma and adenocarcinomas.
  • An in-silico analysis using genetic databases found a total of 26 critical genes associated with both chemical burns and the development of esophageal cancer.
  • The study concludes that chemical burns act as a significant external factor that may worsen prognosis and increase the risk of developing esophageal cancer.
View Article and Find Full Text PDF

Background: Gastric cancer (GC) stands out as one of the most prevalent malignancies affecting the digestive system, characterized by a substantial incidence rate and mortality. Maternal embryonic leucine zipper kinase (MELK) has been implicated in the advancement of various cancer types and the modulation of the tumor microenvironment. This study aims to delve into the involvement of MELK in chemoresistance and the tumor microenvironment of GC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!